Cobicistat/elvitegravir/emtricitabine/tenofovir/dolutegravir/raltegravirVarious toxicities: 10 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1769卷 / 1期

关键词：

D O I：

10.1007/s40278-019-67150-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：136 / 136

相关论文

共 50 条

[1] Cobicistat/elvitegravir/dolutegravir/raltegravirVarious toxicities: 5 case reports
Reactions Weekly, 2018, 1702 (1) : 87 - 87
[2] Abacavir/dolutegravir/lamivudine/cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideVarious toxicities: 7 case reports
Reactions Weekly, 2023, 1980 (1) : 14 - 14
[3] Atropine/cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideVarious toxicities: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 113 - 113
[4] Abacavir/dolutegravir/lamivudine/cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideRenal toxicity: 2 case reports
Reactions Weekly, 2025, 2048 (1) : 14 - 14
[5] Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamideReduced susceptibility to elvitegravir : case report
Reactions Weekly, 2016, 1617 (1) : 72 - 72
[6] Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideAnencephaly: case report
Reactions Weekly, 2018, 1732 (1) : 133 - 133
[7] Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamideAllergic pruritus and peripheral neuropathy : 2 case reports
Reactions Weekly, 2020, 1791 (1) : 76 - 76
[8] Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide/vilanterol/fluticasone-furoateVarious toxicities: case report
Reactions Weekly, 2019, 1770 (1) : 121 - 121
[9] Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamideProfound weight gain: case report
Reactions Weekly, 2020, 1834 (1) : 81 - 81
[10] Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamideRenal tubular acidosis: case report
Reactions Weekly, 2020, 1793 (1) : 138 - 138

← 1 2 3 4 5 →